Form 4: Molina Healthcare Director Richard Zoretic Acquires Shares Under Equity Incentive Plan

Director Richard Zoretic acquired 188 shares of Molina Healthcare common stock on July 1, 2024, as part of the company's 2019 Equity Incentive Plan.

Summary

• Richard Zoretic, a director of Molina Healthcare, Inc., acquired 188 shares of common stock on July 1, 2024.
• The acquisition was made under the company's 2019 Equity Incentive Plan.
• The shares were granted as part of the annual equity award to directors, with one quarter of the $220,000 award granted each quarter.
• The grant was based on the closing price of Molina Healthcare's common stock on July 1, 2024, which was $292.16 per share.
• Following the transaction, Zoretic beneficially owns 6,647 shares indirectly through a trust.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and expected process. The director's acquisition of shares can be seen as a positive sign of confidence in the company's future.

Positives

• The equity incentive plan aligns director interests with shareholder value.
• Director Zoretic's acquisition of shares demonstrates confidence in the company.

Industry Context

Director share acquisitions are common in publicly traded companies as part of compensation packages and to align director interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages, including equity grants, are common across the healthcare industry.
• Companies like UnitedHealth Group, Anthem (now Elevance Health), and Cigna also utilize equity-based compensation for their directors.
• The specific value and structure of these packages vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates